Tag: China CAR-T breakthrough 2024

Home / China CAR-T breakthrough 2024

Categories

NMPA approves zevorcabtagene autoleucel CAR T Cell therapy for R/R multiple myeloma

Zevor-Cel therapy Chinese regulators have approved zevorcabtagene autoleucel (zevor-cel; CT053), an autologous CAR T-cell therapy, for the treatment of adult patients with multiple myeloma that has r...
china-car-t-breakthrough-2024

Scan the code